Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Gastrointestinal Neoplasms × Aprepitant × Clear all

Phase

Phase NA 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 9 Nausea 5 Breast Neoplasms 4 Uterine Cervical Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

Bevacizumab 5 Leucovorin 4 Irinotecan 4 Fluorouracil 4 Capecitabine 3 Oxaliplatin 2 Drug Therapy 2 trifluridine tipiracil drug combination 1 romiplostim 1 napabucasin 1 entecavir 1 encorafenib 1 apatinib 1 abelacimab 1 Sunitinib 1 Specimen Handling 1 S-1 plus cisplatin 1 Radiosurgery 1 Palonosetron 1 Oviposition 1 Nutrition Assessment 1 Nucleotides 1 Methylphenidate 1 Memantine 1 Melatonin 1 Magnetic Resonance Spectroscopy 1 MAA868 1 Levoleucovorin 1 IDRX-42 1 Glutamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03674294 2023-02-08

CINV

Sun Yat-sen University

Phase 3 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡